We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00768287
Recruitment Status : Completed
First Posted : October 8, 2008
Last Update Posted : June 28, 2017
Information provided by (Responsible Party):
Aptevo Therapeutics ( Aptevo BioTherapeutics )